Codes / ICD10CM / O36.1999

O36.1999 Maternal care for other isoimmunization, unspecified trimester, other fetus

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Maternal care for other isoimmunization, unspecified trimester, other fetus
  • ICD Code: O36.1999

Summary

This condition involves medical care and monitoring provided to a pregnant woman who has developed antibodies against fetal antigens other than the Rh factor, with the trimester unspecified and care focused on a fetus other than the first. The care aims to manage potential risks to the fetus and ensure maternal health during pregnancy.

Causes

Isoimmunization occurs when a mother is exposed to fetal blood antigens, triggering the production of antibodies. These antibodies can cross the placenta and attack the red blood cells of the fetus, leading to hemolytic disease. Common non-Rh antigens include Kell, Duffy, and Kidd systems.

Risk Factors

  • Previous pregnancy with a fetus expressing the relevant antigen
  • Blood transfusion with blood containing the antigen
  • Invasive prenatal procedures (e.g., amniocentesis)
  • Abdominal trauma during pregnancy
  • Prior miscarriage or ectopic pregnancy involving a fetus with the antigen

Symptoms

  • Often asymptomatic in the mother
  • Fetal anemia, jaundice, or hydrops fetalis in severe cases
  • Elevated bilirubin levels in the newborn (if born)

Diagnosis

Blood typing and antibody screening to detect specific antibodies. Doppler ultrasound to assess fetal blood flow and anemia. Amniocentesis or cordocentesis to measure bilirubin levels or fetal blood cell counts may be used for confirmation.

Treatment Options

  • Close monitoring of maternal and fetal status
  • Intrauterine transfusions if fetal anemia is severe
  • Early delivery if complications arise
  • Postnatal care for the newborn, including phototherapy or exchange transfusion

Prognosis and Follow-Up

Prognosis depends on the severity of fetal anemia and timely intervention. Regular follow-up is essential to monitor maternal antibody levels and fetal well-being. Long-term outcomes for the fetus may vary based on the extent of hemolytic disease.

Complications

  • Severe fetal anemia
  • Hydrops fetalis (fluid accumulation in fetal tissues)
  • Stillbirth or neonatal death
  • Kernicterus (brain damage from high bilirubin levels)

Lifestyle & Prevention

  • Avoid invasive procedures unless medically necessary
  • Use Rh immune globulin (if applicable) to prevent sensitization
  • Genetic counseling for future pregnancies
  • Prenatal care to detect and manage isoimmunization early

When to Seek Professional Help

Seek immediate medical attention if experiencing abdominal pain, vaginal bleeding, or reduced fetal movement. Regular prenatal visits are critical for monitoring and early intervention.

Tips for Medical Coders

Document the trimester (if known) and specify the fetus (e.g., "other fetus") to ensure accurate coding. Include details of antibody type, monitoring, and interventions provided. Verify that the code aligns with the clinical scenario and documentation.

Book a walkthrough

O36.1999 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.